The First People's Hospital of Yuhang District
Hangzhou, China
NCT Number: NCT02299258
gastric outlet obstruction tailored versus standard stents for malignant gastric outlet obstruction treatments
Looking for future studies?
Notify MeAll sexes
Interventional
Not applicable
Hangzhou, China
To determine the shape of the GOOs, stomach opacifications were performed using contrast media before stenting. In the GOO tailored group (33 cases), the distal stents were semi-spherical with a length of 20 mm and a diameter of 28 mm. The middle stent segments had diameters of 20 mm. The proximal ends of large cup-shaped stents had 53.3 ± 5.5 mm diameters and were 15 or 20 mm long, whereas the large funnel-shaped stents had 33.6 ± 3.6 mm diameters and were 25 or 30 mm long. The control group (32 cases) received standard uncovered stents (semi-spherical, with diameters of 28 mm and 20 mm long).Our hypothesis was that unresectable GOO tailored covered stents are superior to the standard uncovered ones in terms of stent re-obstruction and stent migration. In the current study the efficacy and safety of GOO tailored covered stents for the treatment of non-resectable GOOs caused by distal gastric cancer was compared with standard uncovered stents.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
GOO defined by symptoms resulting in decreased oral intake (nausea, vomiting and inability to eat),the obstruction was caused by primary distal stomach cancer and the site of stenosis was between the gastric body and duodenum bulb
Exclusion criteria
the presence of only mild symptoms in patients who could tolerate a liquid diet, clinical evidence of perforation or peritonitis, evidence of multiple small-bowel obstructions because of peritoneal seeding as well as diabetes or other diseases that affect gastric motility and use of promotility agents.
The ends of the stents were semi-spherical with diameters of 28 mm and length of 20 mm. The length of the stents was 100 mm
cup-shaped or funnel-shaped, according to the shapes of the proximal GOOs.
Time frame: up to 5 years
number of participants considered having efficacious outcome. Efficacy is defined by Ingrowth + overgrowth in this study
Time frame: up to 5 years
bleeding, abdominal pain
The First People's Hospital of Yuhang District
Other
A Multicenter Randomized Controlled Trial of Malignant Gastric Outlet Obstruction: Tailored Partially Covered Stents (Placed Fluoroscopically) Versus Standard Uncovered Stents (Placed Endoscopically)
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT03259763
Digestive System Diseases, Gastric Outlet Obstruction
New Haven, Connecticut, United States
View Trial DetailsNCT05644951
Digestive System Diseases, Gastric Outlet Obstruction
Nagoya, Aichi-ken, Japan
View Trial DetailsNCT03823690
Digestive System Diseases, Gastric Outlet Obstruction
Hong Kong
View Trial DetailsNCT03223480
Digestive System Diseases, Gastric Outlet Obstruction
Hong Kong
View Trial Details